| Dr Robert A Stroth, MD | |
|
6644 E Baywood Ave, Mesa, AZ 85206-1747 | |
| (602) 685-5211 | |
| (602) 685-5325 |
| Full Name | Dr Robert A Stroth |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 6644 E Baywood Ave, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942278866 | NPI | - | NPPES |
| 556102 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 24800 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology Specialist Of Arizona, Llp | 4789583188 | 61 |
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased risk of sexually transmitted diseases.
Keck School of Medicine of USC neuroscientists have unlocked a piece of the puzzle in the fight against Lou Gehrig's disease, a debilitating neurological disorder that robs people of their motor skills.
› Verified 4 days ago
| Entity Name | Pathology Specialist Of Arizona, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174503999 PECOS PAC ID: 4789583188 Enrollment ID: O20040105000801 |
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased risk of sexually transmitted diseases.
Keck School of Medicine of USC neuroscientists have unlocked a piece of the puzzle in the fight against Lou Gehrig's disease, a debilitating neurological disorder that robs people of their motor skills.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert A Stroth, MD Po Box 42210, Phoenix, AZ 85080-2210 Ph: (623) 266-7770 | Dr Robert A Stroth, MD 6644 E Baywood Ave, Mesa, AZ 85206-1747 Ph: (602) 685-5211 |
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the presentation of the CRS-207 Phase 1 study at the AACR Special Conference on Tumor Immunology in Miami, Florida by the Principal Investigator, Dr. Dung Le of the Johns Hopkins Kimmel Cancer Center. Dr. Le reported that CRS-207 intravenous administration was well tolerated in subjects with advanced, treatment-refractory cancers. Dr. Le also reported evidence of immune activation and that 6 out of 17 end-stage cancer patients lived 15 months or longer.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
New research at Washington University School of Medicine in St. Louis points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased risk of sexually transmitted diseases.
Keck School of Medicine of USC neuroscientists have unlocked a piece of the puzzle in the fight against Lou Gehrig's disease, a debilitating neurological disorder that robs people of their motor skills.
› Verified 4 days ago
Dr. Holly Mcdaniel, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 602-685-5211 Fax: 602-685-5325 | |
Dr. Alia Gupta, MBBS Pathology Medicare: Medicare Enrolled Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 602-685-5211 Fax: 602-685-5325 | |
Dr. Concepcion R Roxas, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Mesa, AZ 85206 Phone: 602-685-5211 Fax: 602-685-5325 | |
Dr. Guangming Guo, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 S Crismon Rd, Mesa, AZ 85209 Phone: 602-685-5211 Fax: 602-685-5325 | |
Dr. Stacy J Arnold, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 602-685-5211 Fax: 602-685-5325 | |
Dr. Robert A Stern, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 602-685-5211 Fax: 602-685-5325 | |
Allan M Soo, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1265 W Guadalupe Rd, Ste Nppes, Mesa, AZ 85202 Phone: 480-775-6038 |